Open AccessCharacteristics of COVID-19 and Research Progresses on Genetic Engineering Vaccine Based on Big Data
Author(s) -
Qixing Wei
Publication year - 2022
Publication title -
journal of healthcare engineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.509
H-Index - 29
eISSN - 2040-2309
pISSN - 2040-2295
DOI - 10.1155/2022/9311052
Subject(s) - big data , covid-19 , data science , genetic data , value (mathematics) , computer science , business , medicine , virology , data mining , environmental health , infectious disease (medical specialty) , pathology , population , disease , machine learning , outbreak
Big data platforms can effectively analyze the data and maximize the value of the data by mining the text, digital, video, and image data in various industries. The combination of big data and various industries has brought great changes to the development of the industry. Providing data according to demand can save more time and promote the development of the industry. SARS-CoV-2 (COVID-19) is sweeping across the world, and it has spread to several countries and regions. Human infections have been reported all around the world. Due to the unique characteristics of COVID-19, no specific medicine is available yet to cure patients before the successful research and development of vaccines. Hence, it is of important significance to research and develop vaccines. Guided by the biological characteristics of COVID-19 and the philosophy of synthetic biology, this study reviews the developed genetic engineering vaccines.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom